The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment
Status:
Unknown status
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
To evaluate whether treatment with Estradiol supplementation during the luteal phase improves
IVF outcomes
Patients undergoing IVF treatment with controlled ovarian hyperstimulation using a GnRH
analog will receive 4 mg estradiol valerate in the luteal phase.Patient's followup will
include E2 progesterone and BHCG 14 days after embryo transfer and vaginal ultrasound on day
21 and 28 after embryo transfer